Amlodipine Tablets IP 5mg
Hypertension management is the single largest, steadiest category in any cardiovascular formulary, and Amlodipine has held a place near the top of that list for over three decades for a simple reason: it works, it's well tolerated, and once-daily dosing makes long-term adherence easier than a drug that needs to be taken multiple times a day.
Each tablet contains 5mg of Amlodipine, a long-acting dihydropyridine calcium channel blocker. It works by inhibiting the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle cells, with a selectively greater effect on vascular smooth muscle. That selectivity is clinically important: it means Amlodipine relaxes and dilates blood vessels to lower blood pressure without significantly depressing cardiac contractility the way some other calcium channel blockers can. It's indicated for the treatment of hypertension and for chronic stable or vasospastic angina, either as monotherapy or in combination with other antihypertensive agents.
The pharmacokinetic profile is part of why it's stayed a first-line therapy: a long elimination half-life supports genuine once-daily dosing with a smooth, sustained blood pressure reduction rather than the peaks and troughs that shorter-acting agents can produce. This is one of the reasons it remains a WHO Model List of Essential Medicines entry and a default first-line choice across national hypertension treatment guidelines worldwide.
For a pharmaceutical exporter, cardiovascular generics like this one represent the most predictable, recession-resistant category in the portfolio, since hypertension prevalence and treatment duration make it a chronic, refill-driven product rather than an episodic purchase. Distributors building a cardiovascular range treat Amlodipine as a foundational SKU, not an optional add-on.
We manufacture this to WHO-GMP standards with complete stability and bioequivalence documentation, available under contract manufacturing for a buyer's own brand or supplied under our registered label. Fifteen years of exporting cardiovascular generics from India means the regulatory file behind this product is built for long-term market presence, not a one-time shipment.
